Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2025)
Historic Invested Capital for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $50.5 million.
- Zhengye Biotechnology Holding's Invested Capital changed N/A to $50.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $50.5 million, marking a year-over-year change of. This contributed to the annual value of $50.1 million for FY2024, which is 1558.7% down from last year.
- Per Zhengye Biotechnology Holding's latest filing, its Invested Capital stood at $50.5 million for Q2 2025.
- Over the past 5 years, Zhengye Biotechnology Holding's Invested Capital peaked at $58.2 million during Q4 2023, and registered a low of $50.1 million during Q4 2024.
- In the last 3 years, Zhengye Biotechnology Holding's Invested Capital had a median value of $50.5 million in 2025 and averaged $52.9 million.
- Over the last 5 years, Zhengye Biotechnology Holding's Invested Capital had its largest YoY gain of 1396.97% in 2024, and its largest YoY loss of 1396.97% in 2024.
- Over the past 3 years, Zhengye Biotechnology Holding's Invested Capital (Quarter) stood at $58.2 million in 2023, then dropped by 13.97% to $50.1 million in 2024, then rose by 0.84% to $50.5 million in 2025.
- Its Invested Capital stands at $50.5 million for Q2 2025, versus $50.1 million for Q4 2024 and $58.2 million for Q4 2023.